French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes.

Hypereosinophilia Hypereosinophilic syndromes Management Recommendation

Journal

Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602

Informations de publication

Date de publication:
30 04 2023
Historique:
received: 18 01 2023
accepted: 02 04 2023
medline: 2 5 2023
pubmed: 1 5 2023
entrez: 30 4 2023
Statut: epublish

Résumé

Eosinophilic-related clinical manifestations are protean and the underlying conditions underpinning eosinophilia are highly diverse. The etiological workup of unexplained eosinophilia/hypereosinophilia can be challenging, and can lead sometimes to extensive, inappropriate, costly and/or invasive investigations. To date, guidelines for the etiological workup and management of eosinophilia are mainly issued by hematologists, and thus mostly cover the scope of clonal hypereosinophilic syndromes (HES). Here, thanks to an extensive literature review, and thanks to the joint work of a large panel of experts involving physicians from both adult and pediatric medicine and from various subspecialties (as well as a representative of a patients' association representative), we provide recommendations for both the step-by step diagnostic workup of eosinophilia (whether unexplained or within specific contexts) as well as the management and follow-up of the full spectrum of eosinophilic disorders (including clonal, reactive, lymphocytic and idiopathic HES, as well as single-organ diseases). Didactic prescription summaries intended to facilitate the prescription of eosinophil-targeted drugs are also provided, as are practical diagnostic and therapeutic algorithms. Lastly, this set of recommendations also includes a summary intended for general practitioners, as well as an overview of the therapeutic patient education program set up by the French reference center for HES. Further updates will be mandatory as new validated information emerges.

Identifiants

pubmed: 37122022
doi: 10.1186/s13023-023-02696-4
pii: 10.1186/s13023-023-02696-4
pmc: PMC10148979
doi:

Types de publication

Journal Article Practice Guideline Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100

Informations de copyright

© 2023. The Author(s).

Références

N Engl J Med. 2003 Mar 27;348(13):1201-14
pubmed: 12660384
Am J Hematol. 2012 Jun;87(6):643-5
pubmed: 22473587
J Allergy Clin Immunol Pract. 2021 Sep;9(9):3497-3499.e1
pubmed: 34020050
J Allergy Clin Immunol. 2014 Apr;133(4):1195-202
pubmed: 23987798
J Allergy Clin Immunol Pract. 2021 Sep;9(9):3529-3531.e1
pubmed: 34273579
Blood. 2007 Jun 1;109(11):4635-40
pubmed: 17299092
Br J Haematol. 2020 Mar;188(5):e68-e72
pubmed: 31721154
N Engl J Med. 1994 Feb 24;330(8):535-8
pubmed: 8302319
Blood. 2004 Jun 1;103(11):4050-5
pubmed: 14988154
J Allergy Clin Immunol. 2020 Dec;146(6):1397-1405
pubmed: 32956756
Allergy. 2023 Jan;78(1):47-59
pubmed: 36207764
J Allergy Clin Immunol. 2017 Jun;139(6):2016-2020.e5
pubmed: 28111307
N Engl J Med. 2008 Mar 20;358(12):1215-28
pubmed: 18344568
Autoimmun Rev. 2017 Jan;16(1):1-9
pubmed: 27671089
Nat Commun. 2019 Nov 12;10(1):5120
pubmed: 31719529
Br J Haematol. 2002 Oct;119(1):131-4
pubmed: 12358917
Respir Med Res. 2021 May;79:100821
pubmed: 33984814
Mod Pathol. 2016 Aug;29(8):854-64
pubmed: 27174585
J Am Acad Dermatol. 2023 Jan;88(1):160-163
pubmed: 33188872
Leukemia. 2022 Jul;36(7):1703-1719
pubmed: 35732831
J Allergy Clin Immunol Pract. 2019 Apr;7(4):1347-1351.e3
pubmed: 30317003
Leukemia. 2016 Sep;30(9):1924-6
pubmed: 27125206
Allergy. 2017 Sep;72(9):1338-1345
pubmed: 28226398
Annu Rev Immunol. 2021 Apr 26;39:719-757
pubmed: 33646859
Autoimmun Rev. 2019 Aug;18(8):828-830
pubmed: 31176876
J Allergy Clin Immunol. 2013 Feb;131(2):461-7.e1-5
pubmed: 23040887
Medicine (Baltimore). 2014 Oct;93(17):255-266
pubmed: 25398061
Blood. 2014 Jun 5;123(23):3574-7
pubmed: 24687085
Allergy. 2016 Jun;71(6):803-10
pubmed: 26797802
Respir Med. 2011 Jan;105(1):114-21
pubmed: 21036585
Annu Rev Immunol. 2006;24:147-74
pubmed: 16551246
Clin Immunol. 2022 Apr;237:108982
pubmed: 35307610
Am J Hematol. 2020 Jul;95(7):824-833
pubmed: 32279331
Blood. 2007 Feb 1;109(3):995-1002
pubmed: 17003379
Front Oncol. 2019 Dec 10;9:1374
pubmed: 31921638
Sci Rep. 2021 Mar 18;11(1):6388
pubmed: 33737704
Br J Dermatol. 2013 Nov;169(5):1071-80
pubmed: 23855313
Stroke. 2021 Oct;52(10):e605-e609
pubmed: 34304603
Lancet Infect Dis. 2018 Jan;18(1):e14-e24
pubmed: 28781085
J Allergy Clin Immunol Pract. 2020 Apr;8(4):1329-1340.e3
pubmed: 31863912
J Natl Compr Canc Netw. 2020 Sep;18(9):1248-1269
pubmed: 32886902
J Allergy Clin Immunol Pract. 2023 Apr;11(4):1317-1319.e1
pubmed: 36581069
Arthritis Rheum. 2013 Jan;65(1):270-81
pubmed: 23044708
Haematologica. 2015 Aug;100(8):1086-95
pubmed: 25682606
Arthritis Rheum. 1971 Sep-Oct;14(5):650-65
pubmed: 4328684
Blood. 2016 Feb 18;127(7):948-51
pubmed: 26702067
J Allergy Clin Immunol Pract. 2021 Mar;9(3):1405-1407.e3
pubmed: 33316460
Clin Exp Allergy. 2010 Apr;40(4):563-75
pubmed: 20447076
Clin Chest Med. 2016 Sep;37(3):535-56
pubmed: 27514599
Ann Intern Med. 1982 Jun;96(6 Pt 1):791
pubmed: 7091950
Br J Dermatol. 2006 Oct;155(4):824-6
pubmed: 16965435
N Engl J Med. 1984 Jun 21;310(25):1621-6
pubmed: 6727934
J Exp Med. 2017 Jul 3;214(7):2121-2138
pubmed: 28566277
J Allergy Clin Immunol. 2005 Sep;116(3):531-6
pubmed: 16159620
Leukemia. 2020 Apr;34(4):1090-1101
pubmed: 31740811
Blood. 2015 Aug 27;126(9):1069-77
pubmed: 25964669
J Allergy Clin Immunol. 2007 Sep;120(3):680-7
pubmed: 17628645
J Allergy Clin Immunol. 2021 Apr;147(4):1261-1268.e5
pubmed: 32920094
Expert Rev Clin Immunol. 2016 Oct;12(10):1059-67
pubmed: 27191665
J Allergy Clin Immunol Pract. 2021 Jun;9(6):2426-2439.e7
pubmed: 33545400
Rev Prat. 2019 Sep;69(7):767-773
pubmed: 32233322
Front Med (Lausanne). 2017 Jul 24;4:103
pubmed: 28791287
J Exp Med. 2020 Jun 1;217(6):
pubmed: 32207811
Leukemia. 2013 Nov;27(11):2254-6
pubmed: 23615556
Blood. 2003 Nov 1;102(9):3093-6
pubmed: 12842979
Medicine (Baltimore). 2012 Jul;91(4):e1-e19
pubmed: 22751495
J Heart Lung Transplant. 2014 Aug;33(8):842-50
pubmed: 24709271
Am J Hematol. 2020 Jul;95(7):E172-E174
pubmed: 32243620
N Engl J Med. 2007 Oct 18;357(16):1608-19
pubmed: 17881745
Allergy. 2021 Jan;76(1):71-89
pubmed: 32189356
PLoS One. 2017 Oct 31;12(10):e0185602
pubmed: 29088303
Leuk Res. 2013 Apr;37(4):392-5
pubmed: 23332454
Neurology. 2020 Apr 21;94(16):e1726-e1737
pubmed: 32217776
Am J Surg Pathol. 2021 Feb 1;45(2):193-199
pubmed: 33060403
Pediatr Allergy Immunol. 2020 Apr;31(3):297-302
pubmed: 31725177
Am J Hematol. 2020 Nov;95(11):1314-1323
pubmed: 32720700
Blood. 1996 Mar 15;87(6):2354-60
pubmed: 8630398
Ann Rheum Dis. 2020 Jan;79(1):77-87
pubmed: 31796497
J Allergy Clin Immunol. 2002 Sep;110(3):476-9
pubmed: 12209097
Oncoimmunology. 2020 Apr 7;9(1):1722022
pubmed: 32313716
Am J Hematol. 2022 Jan 1;97(1):129-148
pubmed: 34533850
Intensive Care Med. 2023 Mar;49(3):291-301
pubmed: 36723637
Blood Adv. 2020 Feb 11;4(3):440-443
pubmed: 31995156
J Allergy Clin Immunol. 2012 Sep;130(3):607-612.e9
pubmed: 22460074
J Allergy Clin Immunol. 2010 Jul;126(1):39-44
pubmed: 20538328
Br J Clin Pharmacol. 2017 Feb;83(2):400-415
pubmed: 27543764
Heart. 1998 Apr;79(4):362-7
pubmed: 9616343
J Allergy Clin Immunol. 2010 Jul;126(1):179-81
pubmed: 20639012
N Engl J Med. 2017 May 18;376(20):1921-1932
pubmed: 28514601
Blood. 2019 Nov 21;134(21):1859-1872
pubmed: 31481482
Br J Haematol. 2004 Dec;127(5):477
pubmed: 15566349
Ann Neurol. 2006 Jun;59(6):905-11
pubmed: 16607617
J Allergy Clin Immunol. 1994 Dec;94(6 Pt 2):1318-26
pubmed: 7798572
Front Immunol. 2020 Aug 11;11:1765
pubmed: 32849632
Br J Haematol. 2020 Mar;188(5):e76-e79
pubmed: 31854104
J Allergy Clin Immunol Pract. 2020 Sep;8(8):2718-2726.e2
pubmed: 32344186
Trends Parasitol. 2016 Oct;32(10):798-807
pubmed: 27262918
J Exp Med. 1990 Oct 1;172(4):1271-4
pubmed: 2212954
Front Med (Lausanne). 2017 Dec 05;4:216
pubmed: 29259972
Clin Gastroenterol Hepatol. 2022 Nov;20(11):2474-2484.e3
pubmed: 35181570
J Am Acad Dermatol. 2023 May;88(5):e243-e250
pubmed: 30738125
J Invest Dermatol. 2017 Apr;137(4):951-954
pubmed: 27887955
J Am Coll Cardiol. 2017 Nov 7;70(19):2363-2375
pubmed: 29096807
J Allergy Clin Immunol. 2009 Dec;124(6):1319-25.e3
pubmed: 19910029
Blood. 2017 Feb 9;129(6):704-714
pubmed: 28028030
Am J Gastroenterol. 2017 Dec;112(12):1849-1858
pubmed: 29112200
N Engl J Med. 2019 Apr 4;380(14):1336-1346
pubmed: 30943337
Transplantation. 2015 Nov;99(11):e176-7
pubmed: 26492057
Heart. 2022 Feb;108(3):164-171
pubmed: 34172539
J Clin Invest. 1993 Apr;91(4):1721-30
pubmed: 8386194
Leukemia. 2012 Jan;26(1):162-4
pubmed: 21818111
J Allergy Clin Immunol Pract. 2020 Mar;8(3):1110-1114.e2
pubmed: 31525539
J Allergy Clin Immunol Pract. 2018 Sep - Oct;6(5):1462-1482.e6
pubmed: 29902530
Autoimmun Rev. 2021 Sep;20(9):102889
pubmed: 34237420
Blood. 2022 Sep 15;140(11):1200-1228
pubmed: 35767897
Clin Immunol. 2023 Jun;251:109275
pubmed: 36870379

Auteurs

Matthieu Groh (M)

Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France. m.groh@hopital-foch.com.
Department of Internal Medicine, Hôpital Foch, Suresnes, France. m.groh@hopital-foch.com.
Inserm, U1286 - INFINITE - Institute for Translational Research in Inflammation, University of Lille, CHU Lille, Lille, France. m.groh@hopital-foch.com.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France. m.groh@hopital-foch.com.

Julien Rohmer (J)

Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.
Department of Internal Medicine, University of Sorbonne-Paris-Cité, APHP, CHU Bichat, Paris, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Nicolas Etienne (N)

Department of Infectious Diseases and Tropical Medicine, University of Sorbonne-Paris-Cité, APHP, CHU Necker-Enfants Malades, Paris, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Wadih Abou Chahla (W)

Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.
Department of Pediatric Hematology, University of Lille, CHU Lille, Lille, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Antoine Baudet (A)

Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.
Department of Internal Medicine, CH Annecy Genevois, Metz Tessy, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Aurélie Chan Hew Wai (A)

Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.
Department of Pharmacology, Hôpital Foch, Suresnes, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Cécile Chenivesse (C)

Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.
CNRS, Inserm, Institut Pasteur de Lille, U1019-UMR9017-CIIL-Centre d'Infection et d'Immunité de Lille, University of Lille, CHU Lille, Lille, France.
CRISALIS (Clinical Research Initiative in Severe Asthma: a Lever for Innovation and Science), F-CRIN Network, INSERM US015, Toulouse, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Irena Clisson Rusek (I)

Association Pour l'Information sur les Maladies à Eosinophiles, Bourg-la-Reine, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Vincent Cottin (V)

Department of Respiratory Medicine, Hôpital Louis Pradel, UMR754 INRAE, University of Lyon 1, Hospices Civils de Lyon, Lyon, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Matthieu Decamp (M)

Department of Cytogenetics, CHU de Caen, Caen, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Pascal De Groote (P)

Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.
Department of Cardiology, University of Lille, CHU Lille, Lille, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Fanny Delahousse (F)

, Nantes, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Nicolas Duployez (N)

Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.
Laboratory of Hematology, University of Lille, CHU Lille, Lille, France.
CNRS, Inserm, IRCL, UMR9020 - UMR1277 - Canther - Cancer Heterogeneity, Plasticity and Resistance to Therapies, 59000, Lille, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Stanislas Faguer (S)

Department of Nephrology and Organ Transplantation, University of Paul Sabatier Toulouse III, CHU Toulouse, Toulouse, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Frédéric Gottrand (F)

Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.
Inserm, U1286 - INFINITE - Institute for Translational Research in Inflammation, University of Lille, CHU Lille, Lille, France.
Division of Gastroenterology, Hepatology and Nutrition, Department of Paediatrics, Jeanne de Flandre Children's Hospital, University of Lille, CHU Lille, Lille, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Florent Huang (F)

Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.
Department of Cardiology, Hôpital Foch, Suresnes, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Thierry Leblanc (T)

Pediatric Hematology and Immunology Department, University Sorbonne-Paris-Cité, APHP, CHU Robert Debré, Paris, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Antoine Magnan (A)

Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.
Department of Respiratory Medicine, Hôpital Foch, Suresnes, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Thierry Martin (T)

Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.
Department of Internal Medicine, CHU Strasbourg, Strasbourg, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Geoffrey Mortuaire (G)

Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.
Inserm, U1286 - INFINITE - Institute for Translational Research in Inflammation, University of Lille, CHU Lille, Lille, France.
Otorhinolaryngology-Head and Neck Department, University of Lille, CHU de Lille, Lille, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Antoine Néel (A)

Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.
Department of Internal Medicine, CHU Nantes, Nantes, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Luc Paris (L)

Department of Parasitology and Mycology, Sorbonne Université, APHP, CHU Pitié-Salpêtrière, Paris, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Arnaud Petit (A)

Department of Hematology and Pediatric Oncology, Sorbonne Université, APHP, CHU Armand Trousseau, Paris, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Julien Rossignol (J)

Department of Hematology, University of Sorbonne-Paris-Cité, APHP, CHU Necker, Paris, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Nicolas Schleinitz (N)

Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.
Department of Internal Medicine, APHM, CHU La Timone, Marseille, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Juliette Soret-Dulphy (J)

Centre d'Investigation Clinique, University of Sorbonne-Paris-Cité, AP-HP, CHU St-Louis, Paris, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Delphine Staumont-Salle (D)

Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.
Department of Dermatology, University of Lille, CHU de Lille, Lille, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Benjamin Terrier (B)

Department of Internal Medicine, University of Sorbonne-Paris-Cité, AP-HP, Paris, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Louis Terriou (L)

Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.
Department of Internal Medicine and Clinical Immunology, University of Lille, CHU de Lille, Lille, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Jean-François Viallard (JF)

Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.
Department of Internal Medicine, CHU de Bordeaux, Bordeaux, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Guillaume Lefèvre (G)

Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.
Inserm, U1286 - INFINITE - Institute for Translational Research in Inflammation, University of Lille, CHU Lille, Lille, France.
Department of Internal Medicine and Clinical Immunology, University of Lille, CHU de Lille, Lille, France.
Department of Internal Medicine, CHU de Bordeaux, Bordeaux, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Jean-Emmanuel Kahn (JE)

Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.
Institut d'Immunologie, University of Lille, CHU de Lille, Lille, France.
Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH